Profile data is unavailable for this security.
About the company
Alzex Neuropharma Inc., formerly Trinity Resources Inc., is a biopharmaceutical company. The Company is engaged in research and development targeting treatments of brain diseases. It is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimer’s Disease but can be applied to other neurological diseases due to its platform technology.
- Revenue in USD (TTM)0.00
- Net income in USD-176.09k
- Incorporated1971
- Employees--
- LocationAlzex Neuropharma Inc2850 West Horizon Ridge, Suite 200HENDERSON 89052United StatesUSA
- Phone+1 (310) 435-0435
- Fax+1 (302) 421-5753
- Websitehttps://trinresinc.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roth CH Acquisition Co | 0.00 | 1.69m | 147.79k | -- | 0.0146 | -- | 0.0844 | -- | 1.71 | 1.71 | 0.00 | -2.90 | 0.00 | -- | -- | -- | 14.66 | -- | 16.77 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -77.00 | -- | -- | -- |
| Wealthcraft Capital Inc | 1.59m | -649.00k | 181.62k | 44.00 | -- | -- | -- | 0.1143 | -0.0595 | -0.0595 | 0.1458 | -0.0939 | 2.05 | -- | 3.77 | 36,113.64 | -83.74 | -- | -- | -- | 44.62 | -- | -40.84 | -- | -- | -214.33 | -- | -- | 74.04 | -- | 90.06 | -- | -- | -- |
| Shanrong Biotechnology Corp | 1.32m | -5.08m | 188.85k | 3.00 | -- | -- | -- | 0.1426 | -15.40 | -15.40 | 4.10 | -11.40 | 4.45 | -- | 11.81 | 441,576.70 | -1,705.30 | -- | -- | -- | -- | -- | -383.32 | -- | 0.0315 | -16.22 | -- | -- | 91.44 | -- | -86.62 | -- | -- | -- |
| Trophy Resources Inc | 3.05m | -5.13m | 211.73k | 80.00 | -- | -- | -- | 0.0694 | -94.47 | -94.47 | 31.24 | -0.0996 | 4.03 | -- | 11.22 | 38,150.00 | -677.10 | -499.42 | -- | -1,483.13 | -2.56 | -- | -168.05 | -3,024.14 | 0.3058 | -- | -- | -- | -- | 32.81 | -232.76 | -- | -59.06 | -- |
| Alzex Neuropharma Inc | 0.00 | -176.09k | 212.24k | -- | -- | -- | -- | -- | -0.1309 | -0.1309 | 0.00 | -0.0816 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -12.16 | -- | -- | -100.00 | -- | 48.79 | -- | -- | -- |
| Morgan Group Holding Co | 1.99m | -907.19k | 270.04k | 1.00 | -- | 0.1888 | -- | 0.1355 | -1.51 | -1.51 | 3.32 | 2.38 | 0.6594 | -- | 4.01 | -- | -30.01 | -29.68 | -48.15 | -39.77 | -- | -- | -45.51 | -31.67 | -- | -- | 0.00 | -- | -32.37 | -- | 39.58 | -- | -- | -- |
| Eastern Goldfields Inc | 8.52m | -3.74m | 284.35k | 218.00 | -- | 0.0137 | -- | 0.0334 | -0.3943 | -0.3943 | 0.8943 | 0.1601 | 0.2886 | 12.77 | -- | 39,087.29 | -12.66 | -- | -52.47 | -- | 5.66 | -- | -43.87 | -- | 0.0281 | -0.9625 | 0.7772 | -- | 2.73 | -- | -126.29 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Alzex Neuropharma Inc's reporting currency: US Dollar USD
